Similarily, Jiao et al. [187] demonstrated that a peptide mimicking VGLL4 functions as a physical antagonist of YAP and blocks YAP oncogenic activity at the transcriptional level in gastric cancer, which may provide an option for therapy. The gene discussed is YAP1; the disease is gastric cancer.